Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus.

In order to assess inflammatory features related to severe asthma as compared with mild asthma, we investigated the secretion of 92 kDa gelatinase matrix metalloproteinase (MMP-9) in bronchial lavages of six patients undergoing mechanical ventilation (MV) for status asthmaticus (SA) and in six patients with mild asthma. Ten healthy nonventilated patients and four patients under MV without preexisting respiratory disease were also investigated. Patients with SA were characterized by prominent neutrophilic inflammation (82 +/- 4% versus 10% in mild asthma). On the basis of enzymatic and immunological analysis, results showed an acute 10- to 160-fold increase of 92 kDa gelatinase (MMP-9) concentration in epithelial lining fluid (ELF) from patients with SA, together with activated forms (46 and 26 kDa) of stromelysin-1 matrix metalloproteinase (MMP-3) and detectable concentration of free metallogelatinolytic activity (1-5 micrograms gelatin hydrolyzed/48 h/ml ELF). Concomitant elevated level of tissue inhibitor of metalloproteinase-1 (TIMP-1) was shown only in patients with SA, thus counterbalancing, at least partially, excess of activated 92 kDa gelatinase. Acutely enhanced albumin levels were only observed in patients with SA; in addition, 92 kDa gelatinase and albumin levels were significantly and positively correlated (r = 0.96, p < 0.0001), suggesting that 92 kDa gelatinase may account for increased bronchial permeability in patients with SA. Several arguments support that 92 kDa gelatinase during SA originates both from numerous activated chemoattracted neutrophils and from activated bronchial epithelial cells in response to in situ lung injury. The fact that no relevant change in ELF, albumin, MMP-9, MMP-3, TIMP-1, or laminin degradation products was observed during mild asthma, strongly supports that the mechanism of airway inflammation in SA is quite distinct from that observed in mild asthma.

[1]  F. Saulnier,et al.  Bronchial neutrophilia in patients with noninfectious status asthmaticus. , 1998, American journal of respiratory and critical care medicine.

[2]  J. Buhler,et al.  Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1β and TNF-α. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[3]  C. Delacourt,et al.  Gelatinases in epithelial lining fluid of patients with adult respiratory distress syndrome. , 1997, The American journal of physiology.

[4]  S. Holgate,et al.  Cellular infiltration of the airways in asthma of varying severity. , 1996, American journal of respiratory and critical care medicine.

[5]  J. Buhler,et al.  Expression of Matrix Metalloproteinase Gelatinases A and B by Cultured Epithelial Cells from Human Bronchial Explants* , 1996, The Journal of Biological Chemistry.

[6]  F. Morel,et al.  Differential expression and secretion of gelatinases and tissue inhibitor of metalloproteinase-1 during neutrophil adhesion. , 1996, Biochimica et biophysica acta.

[7]  C. Gilles,et al.  Wound repair-induced expression of a stromelysins is associated with the acquisition of a mesenchymal phenotype in human respiratory epithelial cells. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[8]  C. Delacourt,et al.  Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. , 1996, American journal of respiratory cell and molecular biology.

[9]  M. Arthur,et al.  Augmentation by eosinophils of gelatinase activity in the airway mucosa: comparative effects as a putative mediator of epithelial injury , 1996, British journal of pharmacology.

[10]  C. Delacourt,et al.  Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[11]  Jesse B. Hall,et al.  The assessment and management of adults with status asthmaticus. , 1995, American journal of respiratory and critical care medicine.

[12]  Kwang Woo Kim,et al.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. , 1995, The Journal of allergy and clinical immunology.

[13]  R. Mecham,et al.  Activation of the 92-kDa Gelatinase by Stromelysin and 4-Aminophenylmercuric Acetate , 1995, The Journal of Biological Chemistry.

[14]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[15]  J. Bousquet,et al.  Eosinophil inflammation in asthma. , 1994, American journal of respiratory and critical care medicine.

[16]  R. Sepper,et al.  Gelatinolytic and type IV collagenolytic activity in bronchiectasis. , 1994, Chest.

[17]  M. Martin,et al.  Expression of 72-kDa gelatinase (MMP-2), collagenase (MMP-1), and tissue metalloproteinase inhibitor (TIMP) in primary pig skin fibroblast cultures derived from radiation-induced skin fibrosis. , 1994, The Journal of investigative dermatology.

[18]  W. Parks,et al.  92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. , 1994, The Journal of clinical investigation.

[19]  C. Delacourt,et al.  Matrix metalloproteinase and elastase activities in LPS-induced acute lung injury in guinea pigs. , 1994, The American journal of physiology.

[20]  H. Sabzevari,et al.  Production and regulation of gelatinase B by human T-cells. , 1993, Biochimica et biophysica acta.

[21]  P. Jorens,et al.  Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. , 1993, The American journal of physiology.

[22]  T. Ulich.  Tumor necrosis factor , 1993 .

[23]  C E Reed,et al.  Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? , 1993, The American review of respiratory disease.

[24]  J. Dayer,et al.  Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. , 1992, The Journal of clinical investigation.

[25]  J. Bousquet,et al.  Asthma: a disease remodeling the airways , 1992, Allergy.

[26]  J. Bousquet,et al.  Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. , 1991, The Journal of allergy and clinical immunology.

[27]  R. Hembry,et al.  The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. , 1991, The Biochemical journal.

[28]  W. Busse,et al.  Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. , 1991, The American review of respiratory disease.

[29]  S. Shapiro,et al.  Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. , 1991, Journal of immunology.

[30]  A. Eisen,et al.  Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. , 1990, The Journal of clinical investigation.

[31]  S. Holgate,et al.  SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS , 1989, The Lancet.

[32]  R. Timpl,et al.  Radioimmunoassay of laminin in serum and its application to cancer patients. , 1986, Clinical chemistry.

[33]  R. Crystal,et al.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. , 1986, Journal of applied physiology.

[34]  T. Cawston,et al.  A rapid and reproducible assay for collagenase using [1-14C]acetylated collagen. , 1979, Analytical biochemistry.